ALPS Medical Breakthroughs ETF
SBIO
36 hedge funds and large institutions have $49.1M invested in ALPS Medical Breakthroughs ETF in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
371% more call options, than puts
Call options by funds: $33K | Put options by funds: $7K
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
0.3% more ownership
Funds ownership: 47.16% → 47.47% (+0.3%)
5% less funds holding
Funds holding: 38 → 36 (-2)
8% less capital invested
Capital invested by funds: $53.1M → $49.1M (-$4.02M)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
Miami,
Florida
|
+$1.58M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$566K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$515K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$388K |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
+$358K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$1.13M |
| 2 |
JIP
Jaffetilchin Investment Partners
Tampa,
Florida
|
-$251K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$202K |
| 4 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$165K |
| 5 |
Jane Street
New York
|
-$88.7K |
SBIO Hedge Fund Activity: Q4 2024 in Review
36 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2024, worth a combined $49.1M — down 7.6% from $53.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of SBIO and 5 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 12 added.
The largest buyer was GTS Securities, opening a new position worth an estimated $1.58M. The largest seller was Old Mission Capital, exiting entirely with an estimated $1.13M sold.
- 36 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2024, down from 38 in Q3 2024.
- Funds reported $49.1M of ALPS Medical Breakthroughs ETF stock for Q4 2024, down 7.6% quarter-over-quarter.
- 5 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2024 and 7 closed out, a net change of -2 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q4 2024 was GTS Securities, an estimated $1.58M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q4 2024 was Old Mission Capital, an estimated $1.13M sold.
Based on aggregated 13F filings for Q4 2024.